As of April 2024 Horizon Therapeutics has a market cap of $26.63 Billion. This makes Horizon Therapeutics the world's 715th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $26.63 B | 0% |
2023 | $26.63 B | 3.11% |
2022 | $25.82 B | 5.67% |
2021 | $24.44 B | 51.39% |
2020 | $16.14 B | 137.21% |
2019 | $6.80 B | 106.28% |
2018 | $3.29 B | 37.9% |
2017 | $2.39 B | -8.29% |
2016 | $2.60 B | -24.6% |
2015 | $3.46 B | 116.42% |
2014 | $1.59 B | 217.45% |
2013 | $0.50 B | 250.22% |
2012 | $0.14 B | 84.11% |
2011 | $78.11 M |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $149.03 B | 459.62% | ๐บ๐ธ USA |
Amgen AMGN | $146.72 B | 450.91% | ๐บ๐ธ USA |
Merck MRK | $321.69 B | 1,107.92% | ๐บ๐ธ USA |
AstraZeneca AZN | $220.75 B | 728.89% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $11.89 B | -55.35% | ๐ฎ๐ณ India |